CareLit · DOI-Nachweis · Aktuelle Neurologie
A 2-year longitudinal PBMC gene expression profiling of MS patients receiving interferon-beta 1b predicts therapy outcome
DOI 10.1055/s-2007-987763
Bibliografische Angaben
Nachweis in CareLit
Autor:innenR Goertsches, S Möller, D Koczan, P Serrano-Fernandez, HJ Thiesen, UK Zettl
ZeitschriftAktuelle Neurologie
Ausgabe09/2007
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Objective: A systematic time-dependent gene expression analysis from Interferon beta 1b (IFNbeta-1b) treated Multiple sclerosis (MS) patients delivers sets of genes that provide a rational basis for predicting the success in modulation of the disease course. Background: Microarrays are facilitating medical research by documenting detailed responses of cells and tissues to both disease and the intended and unintended…
Zitieren
Zitierempfehlung
R Goertsches, S Möller, D Koczan, P Serrano-Fernandez, HJ Thiesen, UK Zettl (2007) A 2-year longitudinal PBMC gene expression profiling of MS patients receiving interferon-beta 1b predicts therapy outcome. Aktuelle Neurologie (09). https://doi.org/10.1055/s-2007-987763
Mit CareLit weiterarbeiten